A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab
Saved in:
Main Authors: | Renat Ahatov, BSA (Author), Allison J. Good, MD (Author), Michael Joo, MD (Author), Shelby Tipton, MD (Author), Brandon Goodwin, MD (Author), Brent Kelly, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab
by: Zi-Yi Choo, BS, et al.
Published: (2023) -
Acceleration of cutaneous T-cell lymphoma following dupilumab administration
by: Kristen Russomanno, MD, et al.
Published: (2021) -
Lethal anaplastic large-cell lymphoma occurring in a patient treated with dupilumab
by: Aurélie Du-Thanh, MD, PhD, et al.
Published: (2021) -
Peristomal irritant contact dermatitis treated with dupilumab
by: Emma Villamaria, BSA, et al.
Published: (2023) -
Complete durable remission of a fulminant primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma after autologous and allogeneic hematopoietic stem cell transplantation
by: Kerasia-Maria Plachouri, MD, et al.
Published: (2017)